GE HealthCare Technologies Inc. $GEHC Shares Purchased by Kestra Advisory Services LLC

Key Points

• Kestra Advisory Services LLC increased its stake in GE HealthCare Technologies by 74.1% in the first quarter, acquiring an additional 11,077 shares and bringing its total holdings to 26,028 shares valued at approximately $2.1 million.
• Analysts have set a price target range for GE HealthCare Technologies, with Citigroup raising its target to $93 and Morgan Stanley lowering it to $74, resulting in a consensus rating of "Moderate Buy."
• GE HealthCare Technologies reported earnings of $1.06 per share for its recent quarter, exceeding expectations and demonstrating a 3.5% year-over-year revenue growth to a total of $5 billion.

Kestra Advisory Services LLC boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 74.1% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 26,028 shares of the company's stock after acquiring an additional 11,077 shares during the quarter. Kestra Advisory Services LLC's holdings in GE HealthCare Technologies were worth $2,101,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of GEHC. Boothbay Fund Management LLC purchased a new position in GE HealthCare Technologies in the 4th quarter worth approximately $230,000. Beacon Pointe Advisors LLC boosted its holdings in GE HealthCare Technologies by 12.8% in the 4th quarter. Beacon Pointe Advisors LLC now owns 13,667 shares of the company's stock worth $1,069,000 after acquiring an additional 1,553 shares during the period. Lido Advisors LLC boosted its stake in shares of GE HealthCare Technologies by 9.8% during the 4th quarter. Lido Advisors LLC now owns 10,801 shares of the company's stock valued at $844,000 after buying an additional 967 shares during the last quarter. AQR Capital Management LLC boosted its stake in shares of GE HealthCare Technologies by 13.6% during the 4th quarter. AQR Capital Management LLC now owns 237,322 shares of the company's stock valued at $18,554,000 after buying an additional 28,445 shares during the last quarter. Finally, Utah Retirement Systems boosted its stake in shares of GE HealthCare Technologies by 3.3% during the 4th quarter. Utah Retirement Systems now owns 75,465 shares of the company's stock valued at $5,900,000 after buying an additional 2,400 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have recently commented on GEHC. Wall Street Zen upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating in a research note on Saturday, May 31st. BTIG Research reiterated a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Morgan Stanley reduced their target price on GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating for the company in a research note on Thursday, July 31st. Zacks Research upgraded GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research note on Thursday, August 28th. Finally, Citigroup increased their target price on GE HealthCare Technologies from $89.00 to $93.00 and gave the company a "buy" rating in a research note on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $88.55.

GE HealthCare Technologies Stock Performance

GEHC traded up $0.68 during trading hours on Wednesday, hitting $72.28. 1,850,459 shares of the stock were exchanged, compared to its average volume of 3,957,856. The stock has a 50-day simple moving average of $74.27 and a 200-day simple moving average of $74.40. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The stock has a market cap of $33.00 billion, a price-to-earnings ratio of 14.82, a price-to-earnings-growth ratio of 2.82 and a beta of 1.13. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The firm had revenue of $5 billion for the quarter, compared to analysts' expectations of $4.96 billion. During the same period last year, the business posted $1.00 earnings per share. The firm's revenue for the quarter was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 25th were paid a dividend of $0.035 per share. The ex-dividend date was Friday, July 25th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio (DPR) is 2.87%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.